Advancing Sustainable Implementation of Comprehensive HIV Prevention and Treatment Programs in Faith-based and Private Sites in Nairobi, Coast and Western Regions in the Republic of Kenya under the President’s Emergency Plan for AIDS Relief (PE | CDC RFA GH22 2209

Frequently Asked Questions (FAQs)

1) What is this funding opportunity about?

This opportunity is a CDC cooperative agreement under PEPFAR to strengthen and sustain comprehensive HIV prevention, care, and treatment services delivered through private and faith-based health facilities in Kenya. The focus is on expanding coverage, improving quality, and embedding HIV services into routine health care delivery to support long-term county and community ownership and sustainability.

2) What type of award is being offered?

The award mechanism is a cooperative agreement. This generally means CDC is expected to have substantial involvement during implementation, such as technical direction, collaboration, and oversight, rather than operating as a hands-off funder.

3) Who is the funder and what larger initiative is this tied to?

The funder is the U.S. Centers for Disease Control and Prevention (CDC), and the opportunity is under PEPFAR (the U.S. President's Emergency Plan for AIDS Relief).

4) Where will the supported activities take place?

The program targets three priority geographic areas and partner networks in Kenya:

• Eastern Deanery AIDS Relief Program-affiliated sites serving the eastern slums of Nairobi County
• Coptic Hospital-affiliated sites in Nairobi and Vihiga Counties
• Bomu Hospital-affiliated sites across Mombasa, Kwale, and Kilifi Counties along the Coast

5) What kinds of facilities are the focus of this award?

The opportunity is focused on strengthening HIV services delivered through private and faith-based health facilities and supporting their integration into routine health care delivery and county health systems.

6) What is the overarching goal of the program?

The overarching aim is to expand coverage and improve quality of HIV prevention, care, and treatment services while integrating those services into routine health care so that county health systems and local communities increasingly own, finance, and sustain the work over time.

7) How much funding is anticipated?

CDC anticipates a total funding amount of about USD 29,136,875 for the first year, contingent on the availability of funds.

8) How many awards does CDC expect to make?

CDC expects to make up to five awards.

9) Is there an award ceiling (maximum amount) for Year 1?

An award ceiling is listed as zero for Year 1, which indicates that no maximum cap is specified in the notice. The projected first-year total funding amount provides a general sense of the overall scale.

10) Who is eligible to apply?

The opportunity is open to unrestricted applicants, meaning a broad range of organizations may apply, subject to any eligibility clarifications included in the full notice.

11) What service areas or program components are supported?

The award supports a full continuum of HIV services with an emphasis on integration and efficiency, including:

• HIV testing services (HTS) to identify people living with HIV and link them quickly to care
• Pediatric and adult HIV treatment to improve viral suppression and long-term outcomes
• TB/HIV integrated services (prevention, diagnosis, and treatment)
• Prevention of mother-to-child transmission (PMTCT) to protect infants and advance elimination of MTCT (eMTCT)
• Voluntary medical male circumcision (VMMC) as an evidence-based prevention intervention in appropriate populations and settings

12) Does the opportunity include TB/HIV integration?

Yes. TB/HIV integrated services are a core component, covering tuberculosis prevention, diagnosis, and treatment due to TB being a major cause of illness and death among people living with HIV.

13) Does the program include services for pregnant women and infants?

Yes. PMTCT is included, with the stated intent of protecting infants and progressing toward elimination of mother-to-child transmission (eMTCT).

14) Does the opportunity support voluntary medical male circumcision (VMMC)?

Yes. VMMC is included as an evidence-based HIV prevention intervention in appropriate populations and settings.

15) Are differentiated approaches for specific populations emphasized?

Yes. The notice emphasizes differentiated approaches for groups with elevated risk or unique barriers to care, with tailored, stigma-aware models intended to improve access, retention, and outcomes.

16) Which key populations (KP) are explicitly included?

The opportunity specifically calls out key population services for:

• Female sex workers
• Men who have sex with men
• Transgender people
• People who inject drugs

17) Does the opportunity include programming for orphans and vulnerable children (OVC)?

Yes. OVC programming is included, recognizing HIV's effects on household stability, child wellbeing, and access to services.

18) Does the opportunity include HIV prevention programming for adolescent girls and young women (AGYW)?

Yes. The notice includes HIV prevention programming for AGYW, noting prevention approaches are often linked with broader sexual and reproductive health services and community-based risk reduction.

19) Are laboratory services included in the scope?

Yes. The notice highlights supporting laboratory services, which typically includes strengthening lab networks and quality systems for HIV diagnosis and monitoring (such as viral load testing).

20) What does "strategic information" mean in this opportunity?

The opportunity emphasizes strategic information, including improving data systems, surveillance, reporting, and using data for program improvement. This supports tracking progress along the HIV care cascade and targeting prevention resources where they have the greatest impact.

21) What outcomes is the program aiming to achieve?

Expected results include improved coverage and quality of HIV services across populations served by supported private and faith-based sites, leading to:

• Fewer new HIV infections (reduced incidence)
• Lower illness and death among people living with HIV (reduced morbidity and mortality)
• Progress toward eliminating mother-to-child transmission

22) How does this opportunity address sustainability?

The opportunity reflects a sustainability-oriented approach by embedding HIV services into routine service delivery and strengthening county and community linkages so that local systems increasingly own, finance, and sustain activities over time.

23) What major strategies are emphasized across the program?

Across the described components, the opportunity emphasizes high-quality programming, service integration, efficiency, rapid linkage to care after HIV diagnosis, and strengthening of labs and data systems to continuously improve performance.

24) How is the opportunity aligned with national and global goals?

The work is explicitly aligned with UNAIDS, PEPFAR, and Government of Kenya goals to end AIDS as a public health threat by 2030.

25) What is the funding opportunity number?

The funding opportunity number is CDC RFA GH22 2209.

26) What is the CFDA number listed for this opportunity?

The CFDA number is 93.067.

27) When was the original application closing date?

The original application closing date listed is February 22, 2022.

28) How and when were applications due?

Applications were to be submitted electronically, due by 11:59 pm Eastern Time on the deadline date listed in the notice (with the original closing date stated as February 22, 2022).

29) Is first-year funding guaranteed?

No. The first-year total anticipated amount is described as contingent on the availability of funds.

30) What does it mean that this is intended for "private and faith-based" sites?

Based on the notice description, the intent is to strengthen HIV programming delivered through non-governmental facility networks (private and faith-based health facilities) in the named partner networks and counties, while integrating services into routine care and strengthening linkages with county systems.